BCL2L1 and B-cell chronic lymphocytic leukemia: Significant resistance to the BCL-2/BCL-XL inhibitor ABT-737 was also observed in CLL cells cultured in the presence of IL-4 and CD115-expressing fibroblasts, which induced the expression of BCL-XL and BCL2A1 (22).